Thema: INE987B01026
Natco, INE987B01026
stock-1863880_1920.jpg - Foto: THN
Natco Pharma stock: Promoters acquire 2.21 million rights shares
Natco Pharma stock is in focus after promoter entities acquired shares through the company's rights issue. The allotment changes ownership disclosures.
ad-hoc-news.de, heute 00:51 Uhr
Natco, INE987B01026
Natco Pharma launches Carboplatin generic: what it means ...
The US launch targets a shortage and USD 27.80 million market. Natco Pharma stock has an INR 12.79 billion rights issue through October 22, 2026.
ad-hoc-news.de, 20.10.26 04:05 Uhr
Natco, INE987B01026
Natco Pharma opened a rights issue: what it means for Natco ...
The offer gives two rights shares per 21 held at INR 750 each. For Natco Pharma stock, 17,058,082 shares are offered through October 22, 2026.
ad-hoc-news.de, 14.10.26 00:41 Uhr
Natco, INE987B01026
Natco Pharma stock heads toward a INR 12.7935 billion rights ...
Natco Pharma stock is preparing for a INR 12.7935 billion rights issue opening October 12, 2026. Q1 FY27 revenue fell 42.9 percent year over year.
ad-hoc-news.de, 07.10.26 02:59 Uhr
Natco, INE987B01026
Natco Pharma stock gets an INR 12.79 billion rights issue ...
Natco Pharma stock is tied to a USD 16.70 million eGenesis investment announced September 29, 2026. June-quarter PAT was INR 2.065 billion.
ad-hoc-news.de, 29.09.26 14:54 Uhr
Natco, INE987B01026
Natco Pharma stock faces rights issue decision after 0.15 ...
Natco Pharma stock closed at INR 815.05 on September 22, 2026, down 0.15 percent. June revenue was INR 596.60 crore and profit INR 74.60 crore.
ad-hoc-news.de, 23.09.26 09:47 Uhr
